News Search Results
Jun 18, 2026, 08:00 ET Matica Biotechnology Launches Integrated Korea IIT Platform Solution to Accelerate Global Advanced Therapy Development
emerging advanced therapy companies through collaborative partnerships and open access development strategies.About Matica Biotechnology, Inc.Matica Biotechnology is a viral vector Contract Development and Manufacturing Organization (CDMO) that leverages advanced technologies at its purpose-built
More news about: Matica Biotechnology, Inc.
Jun 18, 2026, 08:00 ET Kalohexis Appoints Xuan Hui, B.Med., M.S., Ph.D., as Director of Corporate Strategy
NORTHBROOK, Ill., June 18, 2026 /PRNewswire/ -- Kalohexis, Inc., a clinical-stage biotechnology company harnessing the melanocortin system to shape the next era of metabolic disease care starting with obesity and cancer cachexia, today announced
More news about: Kalohexis
Jun 18, 2026, 08:00 ET Gandeeva and Zymeworks Use Cryo-EM to Accelerate Antibody Drug Discovery
Inc., a biotech at the forefront of cryo-electron microscopy (cryo-EM)–driven drug design, and Zymeworks Inc. (Nasdaq: ZYME), a global biotechnology company, have partnered to visualize structures of antibody-antigen interfaces at high resolution. While cryo-EM is now used routinely to
More news about: Gandeeva Therapeutics Inc.
Jun 18, 2026, 07:07 ET Six Taipei Biotechs Head to BIO 2026 in San Diego, With Precision Medicine, Drug Delivery, and Bioprocess Innovation in Focus
18, 2026 /PRNewswire/ -- The BIO International Convention, held each June in San Diego, is where dealmaking meets discovery. As the global biotechnology sector continues shifting toward precision medicine, advanced therapeutics, and translational diagnostics, the convention floor has become less
More news about: GeneOnline
Jun 18, 2026, 06:55 ET IASO Bio Announces NDA Approval of Equecabtagene Autoleucel by the Singapore Health Sciences Authority (HSA) for the Treatment of Relapsed or Refractory Multiple Myeloma, Marking a Key Milestone in International Commercialization
SHANGHAI, NANJING, and PLEASANTON, Calif., June 18, 2026 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of novel
More news about: IASO Bio
Jun 18, 2026, 06:45 ET TORL BioTherapeutics Presents Preliminary Safety and Efficacy Data of Ixotatug Vedotin (TORL-1-23) in Combination with Bevacizumab in Recurrent Ovarian Cancer at ESMO Gynaecological Cancers Congress 2026
ANGELES, June 18, 2026 /PRNewswire/ -- TORL BioTherapeutics LLC (TORL), a clinical stage oncology-focused biotechnology company, today announced preliminary Phase 1 safety and efficacy data of ixotatug vedotin (Ixo-V or TORL-1-23) in combination with bevacizumab in
More news about: TORL Biotherapeutics LLC
Jun 18, 2026, 06:15 ET Epson Robots to Showcase SafeSense Technology, High-Performance, Compact SCARA and 6-Axis Solutions and First Look at Epson Collaborative Robot at Automate 2026
of experience, Epson Robots delivers robots for precision assembly and material handling applications in the aerospace, appliance, automotive, biotechnology, consumer product, electronics, food processing, medical device, pharmaceutical, plastics, semiconductor, and telecommunication industries. For
More news about: Epson America, Inc.
Jun 17, 2026, 12:02 ET Metabolic Supply Group Launches Metabolic Research Network (MRN), Connecting Med Spas, Longevity Clinics, and Telehealth Providers to Clinical Research Opportunities Nationwide
innovation while helping advance the future of medicine."The Metabolic Research Network will collaborate with pharmaceutical companies, biotechnology firms, contract research organizations (CROs), academic institutions, decentralized trial operators, and clinical research sites to
More news about: Metabolic Supply Group
Jun 17, 2026, 11:56 ET Lupin Launches Azilsartan Medoxomil Tablets in the United States
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Pharmaceuticals, Inc.
Jun 17, 2026, 10:45 ET The 16th Annual Globee® Awards for Business Invite Healthcare, Medical Technology, and Pharmaceutical Organizations Worldwide to Nominate Their Achievements
participate, including hospitals, healthcare systems, clinics, medical technology companies, diagnostics providers, pharmaceutical organizations, biotechnology companies, healthcare software providers, research-driven organizations, and related institutions worldwide.Nominations are welcomed for
More news about: Globee Awards
Jun 17, 2026, 10:41 ET WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, priced a Public
More news about: WallachBeth Capital LLC
Jun 17, 2026, 10:15 ET Transplant Diagnostics Market worth $8.14 billion by 2031 | MarketsandMarkets™
modernization and automation of diagnostic laboratories, the increasing number of research and development activities outsourced by pharmaceutical and biotechnology companies to independent reference laboratories, and the growing consolidation of diagnostic laboratories in developed countries. Additionally,
More news about: MarketsandMarkets
Jun 17, 2026, 10:01 ET GLP-1 Receptor Agonists Market Gains Momentum as Weight-Loss Drugs Redefine Diabetes and Heart Care - Says Strategic Market Research
Landscape Moves Toward Outcomes, Capacity, and AccessThe GLP-1 Receptor Agonists Market includes major pharmaceutical and biotechnology companies such as Novo Nordisk, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Zealand Pharma, Amgen, and Innovent Biologics.Competition
More news about: Strategic Market Research LLP
Jun 17, 2026, 10:00 ET LG AI Research Announces Collaboration with D&D Pharmatech to accelerate next-generation oral peptide drug discovery
RecommendationsLG AI Research has been steadily developing innovative "Biology AI" models to treat various diseases through the convergence of AI and biotechnology.A prime example is "Cancer Agentic AI," a personalized precision medicine AI platform being developed in collaboration with Professor
More news about: LG
Jun 17, 2026, 09:15 ET LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS
Shareholders,Over the past several months, Lunai Bioworks (NASDAQ: LNAI) has continued to execute its strategy of building a next-generation biotechnology company at the intersection of artificial intelligence, and national security and biology. I would like to update you on developments that have
More news about: Lunai Bioworks Inc.
Jun 17, 2026, 09:00 ET Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969, Achieving First Clinical Milestone in Collaboration with Hygtia Therapeutics
HONG KONG, June 17, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced it has achieved the first clinical milestone in its co-development collaboration
More news about: Insilico Medicine
Jun 17, 2026, 09:00 ET Genprex to Participate at BIO International Convention 2026
[email protected] BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.About Genprex, Inc.Genprex,
More news about: Genprex, Inc.
Jun 17, 2026, 08:31 ET MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum
CAMBRIDGE, Mass., June 17, 2026 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that Hyung Heon Kim, President and Chief Executive Officer, will participate
More news about: MetaVia Inc.
Jun 17, 2026, 08:01 ET Nectin Therapeutics Reports Encouraging Phase 1 Results for NTX1088 in Combination with Keytruda® (pembrolizumab) at ASCO 2026
Therapeutics, LTD.Nectin Therapeutics is a clinical stage biotechnology company devoted to transforming the lives of cancer patients by leveraging unique insights into Nectin pathways to develop the next generation of
More news about: Nectin Therapeutics, LTD.
Jun 17, 2026, 08:00 ET Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond
opportunities in cosmetic skincare and leveraging our microbial engineering platform to explore broader applications in biotechnology products and recombinant proteins.The biotechnology industry is entering a new era where advances in synthetic biology, artificial intelligence and genetic engineering
More news about: Azitra, Inc.
Jun 17, 2026, 08:00 ET Aker BioMarine Strengthens Operational Sustainability Through 24/7 Renewable Energy Agreement with ENGIE
agreement with ENGIE, reinforcing the company's long-term focus on operational sustainability and responsible energy sourcing. As an early mover in the Biotechnology sector, Aker BioMarine is advancing its sustainability efforts through adopting site-specific Renewable Energy Certificates that link each unit
More news about: Engie North America Inc.; Aker BioMarine
Jun 17, 2026, 07:00 ET Triveni Bio Raises $65 Million Series C Financing to Expand Scope of First-in-Class Bispecific TRIV-573 Clinical Studies and Drive Next-Stage Company Growth
WATERTOWN, Mass., June 17, 2026 /PRNewswire/ -- Triveni Bio Inc., a clinical-stage biotechnology company advancing novel antibody treatments for immunological and inflammatory (I&I) disorders, today announced a $65 million Series C financing
More news about: Triveni Bio
Jun 17, 2026, 07:00 ET Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies
www.jazzpharmaceuticals.com for more information.About AbCellera Biologics Inc.AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody-based medicines in the areas of endocrinology, women's health, immunology,
More news about: Jazz Pharmaceuticals plc
Jun 16, 2026, 16:01 ET Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant)
Calif., June 16, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced the closing of its license agreement for VEPPANUTM (vepdegestrant),
More news about: Rigel Pharmaceuticals, Inc.
Jun 16, 2026, 14:00 ET XR and AI Leap into the Future at Augmented World Expo USA 2026 as Expo Hall Opens in Long Beach, CA
Foundation, the platform uses spatial computing and gamification to help students build science confidence and explore potential careers in healthcare, biotechnology, and life sciences. At AWE, attendees can experience live demos that place them inside interactive 3D biological environments, meet virtual microbial
More news about: AWE (Augmented World Expo)